Chinese Upcoming Revised Foreign Investment Catalogue Will Continue To Promote Innovative Drug R&D
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State Council recently announced a plan to revise its Catalogue of Foreign Investment, which guides foreign investment and is, with this edition, opening more high-technology industries to foreign investment to encourage foreign companies to merge with and acquire Chinese firms engaged in high-tech industries
You may also be interested in...
China Releases New Policies To Welcome More Foreign Investment
SHANGHAI - China's State Council released April 13 new guidelines that allow more foreign investment in China that promise a better environment for overseas investment, drawing some relief for industry associations that consider recent policy moves as protectionist and that they say stifle cross-border innovation
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).